Journals / Journal of Turkish Spinal Surgery / 2021 / Cilt: 32 - Sayı: 4

MID-TERM CLINICAL OUTCOMES OF SURGICALLY TREATED MALIGNANT SACRUM TUMORS

Pages
175–178
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It was remarkable that perioperative and postoperative complications were also common.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: There are limited studies in the literature reporting clinical outcomes of malignant sacrum tumors due to their rarity.
📊
Key Findings & Data:Patients’ demographics, type of the tumor, histopathological diagnosis, presence of neurologic deficit, type of approach, type of resection, presence of lumbopelvic fixation, postoperative complications, and recurrence rates were noted from our medical records.
💡
Conclusion & Impact:It was remarkable that perioperative and postoperative complications were also common.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: There are limited studies in the literature reporting clinical outcomes of malignant sacrum tumors due to their rarity. The aim of this study was to evaluate mid-term clinical outcomes of malignant sacrum lesions surgically treated by a single surgeon. Materials and Methods: Patients who were surgically treated with the diagnosis of sacrum tumor were retrospectively analyzed. Patients who underwent surgical resection of malignant sacrum tumors were included. Exclusion criteria were incomplete medical records and follow-ups. Patients’ demographics, type of the tumor, histopathological diagnosis, presence of neurologic deficit, type of approach, type of resection, presence of lumbopelvic fixation, postoperative complications, and recurrence rates were noted from our medical records. Results: A total of 15 patients (7 females, 8 males) with a mean age of 43.3 years participated in the study. The most common histopathological diagnosis of the malignant sacrum tumor was chordoma that was seen in 10 of 15 patients (67%). Soft-tissue tumors (leiomyosarcoma and malignant mesenchymal tumor) were seen in 2 patients (13%), metastatic tumors (renal cell carcinoma and malignant melanoma) in 2 patients (13%), and primary osteogenic tumor (chondrosarcoma) in 1 patient (7%). Perioperative and postoperative complications were encountered in 7 of 15 patients (47%). Conclusion: Chordoma was the most encountered malignant tumor of the sacrum according to our findings. Recurrence of the malignant sacrum tumor was so common that half of our patients had a history of previous treatment. It was remarkable that perioperative and postoperative complications were also common.

🔖

Cite This Article

TURHAN, K., KIZILAY, Y. O., AYDINLI, U., UYSAL, Y., KEZER, M., TEMİZ, A. (2022). MID-TERM CLINICAL OUTCOMES OF SURGICALLY TREATED MALIGNANT SACRUM TUMORS. Journal of Turkish Spinal Surgery, Cilt: 32 - Sayı: 4, 175–178. https://ajindex.com/articles/568575

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Varga PP, Szövérfi Z, Lazary A. Surgical treatment of primary malignant tumors of the sacrum. Neurol Res. 2014;36:577-87
  2. Varga PP, Bors I, Lazary A. Sacral tumors and management. Orthop Clin North Am. 2009;40:105-23
  3. Sciubba DM, Petteys RJ, Garces-Ambrossi GL, Noggle JC, McGirt MJ, Wolinsky JP, et al. Diagnosis and management of sacral tumors. J Neurosurg Spine. 2009;10:244-56
  4. Ruggieri P, Angelini A, Ussia G, Montalti M, Mercuri M. Surgical margins and local control in resection of sacral chordomas. Clin Orthop Relat Res. 2010;468:2939-47
  5. Thornton E, Krajewski KM, O’Regan KN, Giardino AA, Jagannathan JP, Ramaiya N. Imaging features of primary and secondary malignant tumours of the sacrum. Br J Radiol. 2012;85:279-86
  6. Damron TA, Ward WG, Stewart A. Osteosarcoma, chondrosarcoma, and Ewing’s sarcoma: National Cancer Data Base Report. Clin Orthop Relat Res. 2007;459:40-7
  7. Ilaslan H, Sundaram M, Unni KK, Dekutoski MB. Primary Ewing’s sarcoma of the vertebral column. Skeletal Radiol. 2004;33:506-13
  8. Combs SE, Kalbe A, Nikoghosyan A, Ackermann B, Jäkel O, Haberer T, et al. Carbon ion radiotherapy performed as re-irradiation using active beam delivery in patients with tumors of the brain, skull base and sacral region. Radiother Oncol. 2011;98:63-7
  9. Stacchiotti S, Casali PG. Systemic therapy options for unresectable and metastatic chordomas. Curr Oncol Rep. 2011;13:323-30
  10. Stacchiotti S, Longhi A, Ferraresi V, Grignani G, Comandone A, Stupp R, et al. Phase II study of imatinib in advanced chordoma. J Clin Oncol. 2012;30:914-20
  11. Clarke MJ, Dasenbrock H, Bydon A, Sciubba DM, McGirt MJ, Hsieh PC, et al. Posterior-only approach for en bloc sacrectomy: clinical outcomes in 36 consecutive patients. Neurosurgery. 2012;71:357- 64; discussion 364
  12. Court C, Bosca L, Le Cesne A, Nordin JY, Missenard G. Surgical excision of bone sarcomas involving the sacroiliac joint. Clin Orthop Relat Res. 2006;451:189-94
  13. Guo Y, Palmer JL, Shen L, Kaur G, Willey J, Zhang T, et al. Bowel and bladder continence, wound healing, and functional outcomes in patients who underwent sacrectomy. J Neurosurg Spine. 2005;3:106-10
  14. Guo W, Tang X, Zang J, Ji T. One-stage total en bloc sacrectomy: a novel technique and report of 9 cases. Spine (Phila Pa 1976). 2013;38:E626-31. doi: 10.1097/BRS.0b013e31828b7045
  15. Sar C, Eralp L. Surgical treatment of primary tumors of the sacrum. Arch Orthop Trauma Surg. 2002;122:148-55
  16. Wang J, Tang Q, Xie X, Yin J,